Insufficient scRNA-seq data for expression of BGLAP at single-cell level.
Insufficient scRNA-seq data for expression of BGLAP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 288.94 | 2641 / 2642 | 48% | 0.92 | 335 / 705 |
uterus | 100% | 272.12 | 170 / 170 | 46% | 1.00 | 213 / 459 |
prostate | 100% | 394.26 | 245 / 245 | 45% | 0.91 | 224 / 502 |
thymus | 100% | 279.27 | 653 / 653 | 44% | 0.79 | 267 / 605 |
ovary | 100% | 304.58 | 180 / 180 | 34% | 0.63 | 146 / 430 |
pancreas | 94% | 85.42 | 307 / 328 | 39% | 0.70 | 70 / 178 |
kidney | 100% | 212.48 | 89 / 89 | 30% | 0.57 | 274 / 901 |
bladder | 100% | 194.62 | 21 / 21 | 30% | 0.62 | 151 / 504 |
lung | 97% | 134.64 | 558 / 578 | 29% | 0.61 | 335 / 1155 |
adrenal gland | 100% | 195.60 | 257 / 258 | 24% | 0.39 | 56 / 230 |
breast | 99% | 135.53 | 456 / 459 | 23% | 0.44 | 253 / 1118 |
intestine | 99% | 316.99 | 961 / 966 | 18% | 0.29 | 94 / 527 |
liver | 95% | 132.15 | 215 / 226 | 22% | 0.45 | 88 / 406 |
skin | 99% | 112.83 | 1790 / 1809 | 16% | 0.31 | 76 / 472 |
esophagus | 98% | 163.59 | 1421 / 1445 | 16% | 0.28 | 30 / 183 |
stomach | 99% | 135.18 | 355 / 359 | 10% | 0.20 | 30 / 286 |
spleen | 100% | 257.48 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 196.72 | 859 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 162.64 | 1317 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 141.24 | 1182 / 1204 | 0% | 0 | 0 / 0 |
muscle | 92% | 100.66 | 736 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 77.61 | 753 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 0.75 | 13 / 29 |
eye | 0% | 0 | 0 / 0 | 20% | 0.31 | 16 / 80 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.27 | 8 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033574 | Biological process | response to testosterone |
GO_0033280 | Biological process | response to vitamin D |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0036005 | Biological process | response to macrophage colony-stimulating factor |
GO_0043627 | Biological process | response to estrogen |
GO_0007611 | Biological process | learning or memory |
GO_2000224 | Biological process | regulation of testosterone biosynthetic process |
GO_0071305 | Biological process | cellular response to vitamin D |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0007165 | Biological process | signal transduction |
GO_0045124 | Biological process | regulation of bone resorption |
GO_0030500 | Biological process | regulation of bone mineralization |
GO_0007155 | Biological process | cell adhesion |
GO_0014823 | Biological process | response to activity |
GO_0045471 | Biological process | response to ethanol |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_1903011 | Biological process | negative regulation of bone development |
GO_0045670 | Biological process | regulation of osteoclast differentiation |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0033594 | Biological process | response to hydroxyisoflavone |
GO_0032571 | Biological process | response to vitamin K |
GO_0030282 | Biological process | bone mineralization |
GO_0016311 | Biological process | dephosphorylation |
GO_0009629 | Biological process | response to gravity |
GO_0010043 | Biological process | response to zinc ion |
GO_0001956 | Biological process | positive regulation of neurotransmitter secretion |
GO_0007420 | Biological process | brain development |
GO_0001501 | Biological process | skeletal system development |
GO_0050890 | Biological process | cognition |
GO_0009612 | Biological process | response to mechanical stimulus |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0048863 | Biological process | stem cell differentiation |
GO_0060348 | Biological process | bone development |
GO_0044342 | Biological process | type B pancreatic cell proliferation |
GO_1900076 | Biological process | regulation of cellular response to insulin stimulus |
GO_0002076 | Biological process | osteoblast development |
GO_0042593 | Biological process | glucose homeostasis |
GO_0034224 | Biological process | cellular response to zinc ion starvation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0043204 | Cellular component | perikaryon |
GO_0005796 | Cellular component | Golgi lumen |
GO_0030425 | Cellular component | dendrite |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005737 | Cellular component | cytoplasm |
GO_0031982 | Cellular component | vesicle |
GO_0008147 | Molecular function | structural constituent of bone |
GO_0005179 | Molecular function | hormone activity |
GO_0005198 | Molecular function | structural molecule activity |
GO_0046848 | Molecular function | hydroxyapatite binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BGLAP |
Protein name | Osteocalcin (Bone Gla protein) (BGP) (Gamma-carboxyglutamic acid-containing protein) |
Synonyms | |
Description | FUNCTION: Bone protein that constitutes 1-2% of the total bone protein, and which acts as a negative regulator of bone formation . Functions to limit bone formation without impairing bone resorption or mineralization (By similarity). It binds strongly to apatite and calcium . .; FUNCTION: The uncarboxylated form acts as a hormone secreted by osteoblasts, which regulates different cellular processes, such as energy metabolism, male fertility and brain development. Regulates of energy metabolism by acting as a hormone favoring pancreatic beta-cell proliferation, insulin secretion and sensitivity and energy expenditure. Uncarboxylated osteocalcin hormone also promotes testosterone production in the testes: acts as a ligand for G protein-coupled receptor GPRC6A at the surface of Leydig cells, initiating a signaling response that promotes the expression of enzymes required for testosterone synthesis in a CREB-dependent manner. Also acts as a regulator of brain development: osteocalcin hormone crosses the blood-brain barrier and acts as a ligand for GPR158 on neurons, initiating a signaling response that prevents neuronal apoptosis in the hippocampus, favors the synthesis of all monoamine neurotransmitters and inhibits that of gamma-aminobutyric acid (GABA). Osteocalcin also crosses the placenta during pregnancy and maternal osteocalcin is required for fetal brain development. . FUNCTION: The carboxylated form is one of the main organic components of the bone matrix, which constitutes 1-2% of the total bone protein: it acts as a negative regulator of bone formation and is required to limit bone formation without impairing bone resorption or mineralization. The carboxylated form binds strongly to apatite and calcium. .; FUNCTION: The uncarboxylated form acts as a hormone secreted by osteoblasts, which regulates different cellular processes, such as energy metabolism, male fertility and brain development. Regulates of energy metabolism by acting as a hormone favoring pancreatic beta-cell proliferation, insulin secretion and sensitivity and energy expenditure. Uncarboxylated osteocalcin hormone also promotes testosterone production in the testes: acts as a ligand for G protein-coupled receptor GPRC6A at the surface of Leydig cells, initiating a signaling response that promotes the expression of enzymes required for testosterone synthesis in a CREB-dependent manner. Also acts as a regulator of brain development: osteocalcin hormone crosses the blood-brain barrier and acts as a ligand for GPR158 on neurons, initiating a signaling response that prevents neuronal apoptosis in the hippocampus, favors the synthesis of all monoamine neurotransmitters and inhibits that of gamma-aminobutyric acid (GABA). Osteocalcin also crosses the placenta during pregnancy and maternal osteocalcin is required for fetal brain development. . |
Accessions | P84351 ENST00000368272.5 P02818 |